Number of the records: 1  

PEGylated Molybdenum-Iodine Nanocluster as a Promising Radiodynamic Agent against Prostatic Adenocarcinoma

  1. 1.
    SYSNO ASEP0585208
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePEGylated Molybdenum-Iodine Nanocluster as a Promising Radiodynamic Agent against Prostatic Adenocarcinoma
    Author(s) Přibyl, T. (CZ)
    Rumlová, M. (CZ)
    Mikyšková, Romana (UMG-J) RID
    Reiniš, Milan (UMG-J) RID
    Kaňa, A. (CZ)
    Škoch, Karel (UACH-T) SAI, ORCID, RID
    Zelenka, J. (CZ)
    Kirakci, Kaplan (UACH-T) SAI, RID, ORCID
    Ruml, T. (CZ)
    Lang, Kamil (UACH-T) SAI, RID, ORCID
    Number of authors10
    Source TitleInorganic Chemistry. - : American Chemical Society - ISSN 0020-1669
    Roč. 63, č. 9 (2024), s. 4419-4428
    Number of pages10 s.
    Languageeng - English
    CountryUS - United States
    Keywordsinduced photodynamic therapy ; cluster complexes ; cancer ; nanoparticles ; luminescence ; (mo6i8)(4+)
    OECD categoryCell biology
    R&D ProjectsGA21-11688S GA ČR - Czech Science Foundation (CSF)
    Method of publishingLimited access
    Institutional supportUMG-J - RVO:68378050 ; UACH-T - RVO:61388980
    UT WOS001166802200001
    EID SCOPUS85186243334
    DOI10.1021/acs.inorgchem.4c00084
    AnnotationThe combination of photodynamic therapy and radiotherapy has given rise to a modality called radiodynamic therapy (RDT), based on reactive oxygen species-producing radiosensitizers. The production of singlet oxygen, O-2((1)Delta(g)), by octahedral molybdenum (Mo-6) clusters upon X-ray irradiation allows for simplification of the architecture of radiosensitizing systems. In this context, we prepared a radiosensitizing system using copper-free click chemistry between a Mo-6 cluster bearing azido ligands and the homo-bifunctional linker bis-dPEG(11)-DBCO. The resulting compound formed nanoparticles, which featured production of O-2((1)Delta(g)) and efficient cellular uptake, leading to remarkable photo- and radiotoxic effects against the prostatic adenocarcinoma TRAMP-C2 cell line. Spheroids of TRAMP-C2 cells were also used for evaluation of toxicity and phototoxicity. In vivo experiments on a mouse model demonstrated that subcutaneous injection of the nanoparticles is a safe administration mode at a dose of up to 0.08 g kg(-1). The reported results confirm the relevancy of Mo-6-based radiosensitizing nanosystems for RDT.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2025
    Electronic addresshttps://pubs.acs.org/doi/10.1021/acs.inorgchem.4c00084
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.